Narkosen Stockholm AB

ABDissolved

Org 5594067513Medical specialists activities · NACE 8622Est. 20220 employees

Overview Financials People & ownership Related companies

Narkosen Stockholm AB is a Swedish AB, operating in the Specialistläkarverksamhet inom öppenvård, ej på sjukhus sector. Incorporated in 2022, the company has 0 employees and reported revenue of SEK 69K in its latest annual filing.

Revenue 2024

SEK 69K

-87% vs 2023

EBITDA margin

-40.7%

-107% vs 2023

Equity ratio

63.7%

Financial strength

Net profit 2024

SEK 58K

-75% vs 2023

EBITDA — year on year

SEK millions

Key figures

Annual report 2024

Revenue	SEK 69K	-87%
EBITDA	SEK -28K	-107%
Net profit	SEK 58K	-75%
Total assets	SEK 260K	-40%
Equity	SEK 165K	-36%
Employees	0	—

Contact

Address

info@bolagspartner.se

Risika for professionals

Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.

Visit risika.com

Frequently asked questions

What is the Org number of Narkosen Stockholm AB?

Narkosen Stockholm AB is registered with Bolagsverket / SCB under Org 5594067513.

What is the revenue of Narkosen Stockholm AB?

Narkosen Stockholm AB reported revenue of SEK 69K in 2024.

Who is the CEO of Narkosen Stockholm AB?

Per Anders Nihlén is Deputy Chief Executive Officer of Narkosen Stockholm AB, in role since 2022.

Who is the chairman of Narkosen Stockholm AB?

Sandra Christina Nihlén chairs the board of Narkosen Stockholm AB, in role since 2022.

Narkosen Stockholm AB

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on Narkosen Stockholm AB

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on Narkosen Stockholm AB